Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03211390 · ClinicalTrials.gov registry record
Using Telemedicine to Improve Spasticity Diagnosis Rates
A clinical trial of Nervous System Diseases and Spasticity, Muscle, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT03211390: Completed study of Nervous System Diseases and Spasticity, Muscle, sponsored by Vanderbilt University Medical Center.
NCT03211390 is a study of Nervous System Diseases and Spasticity, Muscle that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 321-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03211390, a study of Nervous System Diseases and Spasticity, Muscle, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the reliability of using telemedicine so a neurologist can remotely identify residents of a long-term care facility who should be referred to a neurologist for an in-person spasticity consultation.
Primary Outcome
A Vanderbilt neurologist will examine all consented residents for spasticity using a telemedicine platform, with the assistance of a nurse at the subject's bedside. The findings of the exam will be recorded by the research coordinator. Agreement on spasticity referral between the Vanderbilt neurologist who performed the teleneurological examination and the neurologist who performed the "gold standard" examination will be determined.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Neurological Examination
- DIAGNOSTIC_TEST Teleneurological Examination
Study Locations (1)
Tennessee
- Tennessee State Veterans' Homes - Murfreesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2018-08-01 |
What the finished NCT03211390 record still lists
NCT03211390 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 321-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (81% lower).
The record links to 9 conditions, with Nervous System Diseases appearing as the primary indexed condition, and to 2 interventions - of which Neurological Examination is the first listed.
NCT03211390 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03211390 about?
NCT03211390 is a clinical study titled "Using Telemedicine to Improve Spasticity Diagnosis Rates". The purpose of this study is to test the reliability of using telemedicine so a neurologist can remotely identify residents of a long-term care facility who should be referred to a neurologist for an in-person spasticity consultation.
What is the current status of trial NCT03211390?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-01-30. Estimated completion is 2018-08-01.
What conditions does trial NCT03211390 study?
This clinical trial studies the following conditions: Nervous System Diseases, Spasticity, Muscle, Muscle Spasticity, Neuromuscular Manifestations, Neurologic Manifestations.
What interventions are being tested in trial NCT03211390?
The interventions under investigation include: Neurological Examination (DIAGNOSTIC_TEST), Teleneurological Examination (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03211390?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03211390 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nervous System Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03211390's enrollment target sits among peer trials
60 17th of 23 higher than 6 of 23 other Nervous System Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nervous System Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Rett Syndrome Registry
RECRUITING
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI